Has Jonathan Scholl, MD received payments from drug or device companies?

Yes. Drug and device makers reported $11,131 in general payments to Jonathan Scholl, MD across 230 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jonathan Scholl, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jonathan Scholl, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jonathan Scholl, MD

Interventional Pain Medicine · Indiana, PANPI 1467907253

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $9,418 of the $11,131 with a category attached, or 84.6%. 15 manufacturers reported payments, led by Abbott at 44.7% of the total.

$11,131in general payments, 2019–2025

Across 230 payments — averaging $48.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$5K
Boston Scientific$3K
Medtronic$2K
Si-bone, Inc.$494
Averitas Pharma Inc.$436
GRT US Holding, Inc.$160
plus $457 from 9 others

What the payments were for

Travel & lodging$1,71315%
Food & beverage$9,41885%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	108	$4,980
Boston Scientific	57	$3,023
Medtronic(2 entities)	19	$1,581
Si-bone, Inc.	10	$494
Averitas Pharma Inc.	12	$436
GRT US Holding, Inc.	8	$160
MML US, Inc.	1	$139
Curonix LLC	3	$91
Nevro Corp.	2	$53
Collegium Pharmaceutical, Inc.	3	$44
SPR Therapeutics, Inc	2	$39
Lundbeck LLC	2	$33
Virtus Pharmaceuticals LLC	1	$24
Vertex	1	$19
Electronic Waveform Lab, Inc.	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,131 in reported general payments places this provider in the 85th percentile of 59 interventional pain medicine providers in Pennsylvania.

See all interventional pain medicine providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$92,410

Medicare patients

317

Services billed

1,094

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Buprenorphine	37	$8,260
Gabapentin	250	$2,424
Pregabalin	93	$2,317
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	153	$2,315
Duloxetine Hcl	189	$2,005
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	120	$1,672
Fentanyl	11	$869
Venlafaxine Hcl ErVenlafaxine Hcl	61	$633
Morphine Sulfate ErMorphine Sulfate	20	$436
Nortriptyline Hcl	44	$369
Tramadol Hcl	60	$333
Oxycodone Hcl	23	$313
Diclofenac Sodium	21	$292
Desvenlafaxine Succinate ErDesvenlafaxine Succinate	11	$260
Hydromorphone Hcl	15	$252

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Indiana

Michael FishmanLebanon$670K
David ProvenzanoSewickley$198K
Michael FarrellPittsburgh$23K
Farshad RashidianWest Chester$19K
Chad MetzgerDarby$14K
Jorge Rivero-BecerraPittsburgh$12K
James BresnahanSpringfield$12K
Nathan MaltezosWest Chester$10K
Mark BellPlains$9K
Danish QureshiPittsburgh$8K

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →